H. Guo

175TiP A prospective phase II study to investigate the efficacy and safety of olaparib plus abiraterone and prednisone combination therapy in mHSPC patients with HRR gene mutation

S. Zhang, X. Qiu, J. Zhuang, 2022, Annals of Oncology.